Endava (NYSE: DAVA) posts Q2 revenue drop and swings to loss
Endava plc reported weaker results for Q2 FY2026 as it ramps AI investments. Revenue was £184.1 million, down 5.9% year over year, though up 3.3% from Q1’s £178.2 million. At constant currency, revenue declined 5.1%.
The company swung to a loss before tax of £7.2 million versus a £2.5 million profit a year earlier. Diluted EPS was £(0.13) compared with £0.11, while adjusted diluted EPS fell to £0.16 from £0.30 as the adjusted profit before tax margin dropped to 5.8% from 11.2%.
Operating cash generation remained solid but softer, with net cash from operating activities of £28.2 million versus £32.0 million and adjusted free cash flow of £20.1 million versus £31.6 million. Cash and cash equivalents increased to £68.5 million from £59.3 million at June 30, 2025.
Client and headcount metrics softened: clients over £1 million in trailing-12‑month revenue fell to 135 from 141, and headcount edged down to 11,385 from 11,668. Endava has repurchased 8,047,338 ADSs for $121.9 million, with $28.1 million remaining under its authorization.
For Q3 FY2026, Endava guides revenue to £182.0–£185.0 million, implying a constant-currency decline of 4.0% to 2.5%, and adjusted diluted EPS of £0.18–£0.21. For full-year FY2026, it expects revenue of £736.0–£750.0 million, a constant-currency decline of 3.5% to 1.5%, and adjusted diluted EPS of £0.80–£0.86.
Positive
- Solid cash generation and liquidity: Q2 FY2026 net cash from operating activities was £28.2 million and adjusted free cash flow was £20.1 million, while cash and cash equivalents rose to £68.5 million from £59.3 million at June 30, 2025.
- Meaningful share repurchases: As of January 31, 2026, Endava had repurchased 8,047,338 American Depositary Shares for $121.9 million, with $28.1 million remaining under the existing authorization.
Negative
- Revenue contraction and loss-making quarter: Q2 FY2026 revenue declined 5.9% year over year to £184.1 million, and the company reported a £7.2 million loss before tax versus a £2.5 million profit in the prior-year quarter.
- Sharp margin and EPS deterioration: Adjusted profit before tax fell to £10.7 million with a 5.8% margin from £21.8 million and 11.2%, and adjusted diluted EPS dropped to £0.16 from £0.30 year over year.
- Softer client and growth outlook: Clients generating over £1 million in annual revenue decreased from 141 to 135, and guidance for FY2026 implies constant-currency revenue decline between 3.5% and 1.5% with lower adjusted EPS than the prior year.
Insights
Endava shows revenue decline, margin compression and cautious guidance despite solid cash flow and buybacks.
Endava delivered Q2 FY2026 revenue of £184.1 million, down 5.9% year over year and 5.1% lower at constant currency. The shift to AI-native capabilities appears to be weighing on near-term profitability, with loss before tax of £7.2 million versus a prior-year profit.
Adjusted profitability weakened meaningfully: adjusted profit before tax fell to £10.7 million with a 5.8% margin, roughly half the 11.2% margin a year earlier, and adjusted diluted EPS declined from £0.30 to £0.16. Client metrics also softened, with clients contributing over £1 million in annual revenue dropping from 141 to 135.
Cash generation, however, remained healthy, with Q2 net cash from operating activities of £28.2 million and adjusted free cash flow of £20.1 million. The company held £68.5 million of cash at December 31, 2025 and has repurchased 8,047,338 ADSs for $121.9 million. Guidance for Q3 and full-year FY2026 points to continued revenue decline at constant currency and lower adjusted EPS versus the prior year.
| Exhibit | Description | |||||||
| 99.1 | Press Release dated February 19, 2026 | |||||||
| 99.2 | Investor Presentation Q2 FY26 | |||||||
| ENDAVA PLC | |||||||||||
| Date: February 19, 2026 | By: | /s/ John Cotterell | |||||||||
| Name: John Cotterell | |||||||||||
| Title: Chief Executive Officer | |||||||||||
![]() | Q2 FY2026 | |||||||
![]() | Q2 FY2026 | |||||||
![]() | Q2 FY2026 | |||||||
![]() | Q2 FY2026 | |||||||
![]() | Q2 FY2026 | |||||||
![]() | Q2 FY2026 | |||||||
![]() | Q2 FY2026 | |||||||
![]() | Q2 FY2026 | |||||||
| CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | Six Months Ended December 31 | Three Months Ended December 31 | ||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| £’000 | £’000 | £’000 | £’000 | |||||||||||
| REVENUE | 362,285 | 390,641 | 184,098 | 195,589 | ||||||||||
| Cost of sales | ||||||||||||||
| Direct cost of sales | (273,839) | (283,066) | (139,800) | (143,546) | ||||||||||
| Allocated cost of sales | (13,180) | (13,898) | (6,696) | (7,025) | ||||||||||
| Total cost of sales | (287,019) | (296,964) | (146,496) | (150,571) | ||||||||||
| GROSS PROFIT | 75,266 | 93,677 | 37,602 | 45,018 | ||||||||||
| Selling, general and administrative expenses | (81,131) | (87,314) | (40,556) | (43,345) | ||||||||||
| OPERATING (LOSS) / PROFIT | (5,865) | 6,363 | (2,954) | 1,673 | ||||||||||
| Net finance (expense) / income | (9,833) | 354 | (4,272) | 831 | ||||||||||
| (LOSS) / PROFIT FOR THE PERIOD BEFORE TAX | (15,698) | 6,717 | (7,226) | 2,504 | ||||||||||
| Tax on (loss) / profit on ordinary activities | 635 | 2,381 | 320 | 4,347 | ||||||||||
| (LOSS) / PROFIT FOR THE PERIOD | (15,063) | 9,098 | (6,906) | 6,851 | ||||||||||
| OTHER COMPREHENSIVE INCOME | ||||||||||||||
| Items that may be reclassified subsequently to profit or loss: | ||||||||||||||
| Exchange differences on translating foreign operations and net investment hedge impact | 5,874 | (13,813) | (719) | 9,527 | ||||||||||
| Total comprehensive (expense) / income for the year attributable to the equity holders of the Company | (9,189) | (4,715) | (7,625) | 16,378 | ||||||||||
| (LOSS) / EARNINGS PER SHARE: | ||||||||||||||
| Weighted average number of shares outstanding - Basic | 52,957,541 | 59,269,752 | 52,877,958 | 59,488,389 | ||||||||||
| Weighted average number of shares outstanding - Diluted | 52,957,541 | 59,472,250 | 52,877,958 | 59,628,436 | ||||||||||
| Basic (Loss) / EPS (£) | (0.28) | 0.15 | (0.13) | 0.12 | ||||||||||
| Diluted (Loss) / EPS (£) | (0.28) | 0.15 | (0.13) | 0.11 | ||||||||||
![]() | Q2 FY2026 | |||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | December 31, 2025 | June 30, 2025 | December 31, 2024 (1) | ||||||||
| £’000 | £’000 | £’000 | |||||||||
| ASSETS - NON-CURRENT | |||||||||||
| Goodwill | 478,156 | 473,296 | 500,958 | ||||||||
| Intangible assets | 99,677 | 100,890 | 117,095 | ||||||||
| Property, plant and equipment | 14,809 | 14,177 | 16,603 | ||||||||
| Lease right-of-use assets | 41,261 | 41,515 | 47,459 | ||||||||
| Deferred tax assets | 22,068 | 19,030 | 21,466 | ||||||||
| Financial assets and other receivables | 6,096 | 5,009 | 9,005 | ||||||||
| TOTAL | 662,067 | 653,917 | 712,586 | ||||||||
| ASSETS - CURRENT | |||||||||||
| Trade and other receivables | 196,607 | 209,523 | 190,059 | ||||||||
| Corporation tax receivable | 1,082 | 12,865 | 10,072 | ||||||||
| Financial assets | 117 | 121 | 118 | ||||||||
| Cash and cash equivalents | 68,484 | 59,345 | 60,065 | ||||||||
| TOTAL | 266,290 | 281,854 | 260,314 | ||||||||
| TOTAL ASSETS | 928,357 | 935,771 | 972,900 | ||||||||
| LIABILITIES - CURRENT | |||||||||||
| Lease liabilities | 13,815 | 13,661 | 14,457 | ||||||||
| Trade and other payables | 91,827 | 96,827 | 106,263 | ||||||||
| Corporation tax payable | 3,422 | 7,757 | 6,832 | ||||||||
| Contingent consideration | 74 | 100 | 3,577 | ||||||||
| Deferred consideration | 2,487 | 3,376 | 4,170 | ||||||||
| TOTAL | 111,625 | 121,721 | 135,299 | ||||||||
| LIABILITIES - NON CURRENT | |||||||||||
| Borrowings | 202,745 | 180,943 | 123,669 | ||||||||
| Lease liabilities | 32,888 | 33,448 | 37,711 | ||||||||
| Deferred tax liabilities | 14,203 | 15,183 | 19,974 | ||||||||
| Tax liabilities related to Pilar II Income tax | 584 | 584 | — | ||||||||
| Contingent consideration | — | 401 | 1,155 | ||||||||
| Deferred consideration | 278 | — | — | ||||||||
| Other liabilities | 599 | 552 | 377 | ||||||||
| TOTAL | 251,297 | 231,111 | 182,886 | ||||||||
| EQUITY | |||||||||||
| Share capital | 1,061 | 1,123 | 1,189 | ||||||||
| Share premium | 21,280 | 21,280 | 21,280 | ||||||||
| Merger relief reserve | 63,440 | 63,440 | 63,440 | ||||||||
| Retained earnings | 536,155 | 575,428 | 602,688 | ||||||||
| Other reserves | (54,418) | (60,369) | (33,872) | ||||||||
| Treasury shares | (2,078) | (17,958) | — | ||||||||
| Investment in own shares | (5) | (5) | (10) | ||||||||
| TOTAL | 565,435 | 582,939 | 654,715 | ||||||||
| TOTAL LIABILITIES AND EQUITY | 928,357 | 935,771 | 972,900 | ||||||||
![]() | Q2 FY2026 | |||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | Six Months Ended December 31 | Three Months Ended December 31 | ||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| £’000 | £’000 | £’000 | £’000 | |||||||||||
| OPERATING ACTIVITIES | ||||||||||||||
| (Loss) / Profit for the period | (15,063) | 9,098 | (6,906) | 6,851 | ||||||||||
| Income tax charge | (635) | (2,381) | (320) | (4,347) | ||||||||||
| Non-cash adjustments | 37,665 | 46,207 | 17,673 | 22,614 | ||||||||||
| Tax received / (paid) | 3,894 | (3,786) | (1,787) | (2,466) | ||||||||||
| Research & Development Credit received | 3,871 | — | 3,774 | — | ||||||||||
| Net changes in working capital | 10,678 | (12,716) | 15,724 | 9,396 | ||||||||||
| Net cash from operating activities | 40,410 | 36,422 | 28,158 | 32,048 | ||||||||||
| INVESTING ACTIVITIES | ||||||||||||||
| Purchase of non-current assets (tangibles and intangibles) | (11,127) | (1,571) | (8,037) | (436) | ||||||||||
| Proceeds from disposal of non-current assets | 63 | 36 | 16 | — | ||||||||||
| Payment for acquisition of subsidiary, net of cash acquired | (3,586) | (5,900) | (99) | (5,832) | ||||||||||
| Interest received | 1,249 | 720 | 555 | 353 | ||||||||||
| Net cash used in investing activities | (13,401) | (6,715) | (7,565) | (5,915) | ||||||||||
| FINANCING ACTIVITIES | ||||||||||||||
| Proceeds from borrowings | 43,000 | 10,000 | 33,000 | 10,000 | ||||||||||
| Repayment of borrowings | (23,330) | (30,842) | (23,330) | (23,842) | ||||||||||
| Proceeds from sublease | 53 | 64 | 30 | 34 | ||||||||||
| Repayment of lease liabilities | (6,583) | (6,159) | (3,685) | (3,066) | ||||||||||
| Repayment of lease interest | (855) | (989) | (438) | (482) | ||||||||||
| Grant received | 10 | 274 | 10 | |||||||||||
| Interest and debt financing costs paid | (5,162) | (4,282) | (2,694) | (2,030) | ||||||||||
| Payment for repurchase of own shares | (24,985) | (2,068) | ||||||||||||
| Net cash (used in) / provided by financing activities | (17,852) | (31,934) | 825 | (19,386) | ||||||||||
| Net change in cash and cash equivalents | 9,157 | (2,227) | 21,418 | 6,747 | ||||||||||
| Cash and cash equivalents at the beginning of the period | 59,345 | 62,358 | 47,225 | 52,811 | ||||||||||
| Effects of exchange rate changes on cash and cash equivalents | (18) | (66) | (159) | 507 | ||||||||||
| Cash and cash equivalents at the end of the period | 68,484 | 60,065 | 68,484 | 60,065 | ||||||||||
![]() | Q2 FY2026 | |||||||
| Six Months Ended December 31 | Three Months Ended December 31 | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| REVENUE (DECLINE) / GROWTH RATE AS REPORTED UNDER IFRS | (7.3) | % | 5.0 | % | (5.9 | %) | 6.6 | % | ||||||
| Impact of Foreign exchange rate fluctuations | 1.0 | % | 2.0 | % | 0.8 | % | 2.5 | % | ||||||
| REVENUE (DECLINE) / GROWTH RATE AT CONSTANT CURRENCY | (6.3) | % | 7.0 | % | (5.1 | %) | 9.1 | % | ||||||
| Six Months Ended December 31 | Three Months Ended December 31 | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| £’000 | £’000 | £’000 | £’000 | |||||||||||
| (LOSS) / PROFIT BEFORE TAX | (15,698) | 6,717 | (7,226) | 2,504 | ||||||||||
| Adjustments: | ||||||||||||||
| Share-based compensation expense | 14,176 | 21,965 | 6,496 | 10,944 | ||||||||||
| Amortisation of acquired intangible assets | 10,170 | 12,182 | 5,149 | 6,036 | ||||||||||
| Foreign currency exchange losses / (gains), net | 4,842 | (3,420) | 1,294 | (2,574) | ||||||||||
| Restructuring costs | 6,531 | 5,494 | 4,093 | 5,494 | ||||||||||
| Exceptional people charges | 668 | — | 668 | — | ||||||||||
| Fair value movement of contingent consideration | (169) | (1,871) | 194 | (569) | ||||||||||
| Total adjustments | 36,218 | 34,350 | 17,894 | 19,331 | ||||||||||
| ADJUSTED PROFIT BEFORE TAX | 20,520 | 41,067 | 10,668 | 21,835 | ||||||||||
| (LOSS) / PROFIT FOR THE PERIOD | (15,063) | 9,098 | (6,906) | 6,851 | ||||||||||
| Adjustments: | ||||||||||||||
| Adjustments to (loss) / profit before tax | 36,218 | 34,350 | 17,894 | 19,331 | ||||||||||
| Release of Romanian withholding tax | — | (3,800) | — | (3,800) | ||||||||||
| Tax impact of adjustments | (4,642) | (6,682) | (2,397) | (4,511) | ||||||||||
| ADJUSTED PROFIT FOR THE PERIOD | 16,513 | 32,966 | 8,591 | 17,871 | ||||||||||
![]() | Q2 FY2026 | |||||||
| Six Months Ended December 31 | Three Months Ended December 31 | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| £’000 | £’000 | £’000 | £’000 | |||||||||||
| DILUTED (LOSS) / EARNINGS PER SHARE (£) | (0.28) | 0.15 | (0.13) | 0.11 | ||||||||||
| Adjustments: | ||||||||||||||
| Share-based compensation expense | 0.27 | 0.37 | 0.12 | 0.18 | ||||||||||
| Amortisation of acquired intangible assets | 0.19 | 0.20 | 0.10 | 0.10 | ||||||||||
| Foreign currency exchange losses / (gains) net | 0.09 | (0.06) | 0.03 | (0.03) | ||||||||||
| Restructuring costs | 0.12 | 0.09 | 0.08 | 0.09 | ||||||||||
| Exceptional people charges | 0.01 | — | 0.01 | — | ||||||||||
| Fair value movement of contingent consideration | — | (0.02) | — | (0.01) | ||||||||||
| Release of Romanian withholding tax | — | (0.06) | — | (0.06) | ||||||||||
| Tax impact of adjustments | (0.09) | (0.12) | (0.05) | (0.08) | ||||||||||
| Total adjustments | 0.59 | 0.40 | 0.29 | 0.19 | ||||||||||
| ADJUSTED DILUTED EARNINGS PER SHARE (£) | 0.31 | 0.55 | 0.16 | 0.30 | ||||||||||
| Six Months Ended December 31 | Three Months Ended December 31 | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| £’000 | £’000 | £’000 | £’000 | |||||||||||
| NET CASH FROM OPERATING ACTIVITIES | 40,410 | 36,422 | 28,158 | 32,048 | ||||||||||
| Adjustments: | ||||||||||||||
| Grant received | 10 | 274 | 10 | — | ||||||||||
| Net purchases of non-current assets (tangibles and intangibles) | (11,064) | (1,535) | (8,021) | (436) | ||||||||||
| ADJUSTED FREE CASH FLOW | 29,356 | 35,161 | 20,147 | 31,612 | ||||||||||
![]() | Q2 FY2026 | |||||||
| Six Months Ended December 31 | Three Months Ended December 31 | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| £’000 | £’000 | £’000 | £’000 | |||||||||||
| Direct cost of sales | 9,283 | 15,048 | 4,419 | 7,254 | ||||||||||
| Selling, general and administrative expenses | 4,893 | 6,917 | 2,077 | 3,690 | ||||||||||
| Total | 14,176 | 21,965 | 6,496 | 10,944 | ||||||||||
| Six Months Ended December 31 | Three Months Ended December 31 | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| £’000 | £’000 | £’000 | £’000 | |||||||||||
| Direct cost of sales | 9,282 | 10,413 | 4,691 | 5,233 | ||||||||||
| Selling, general and administrative expenses | 11,503 | 13,720 | 5,802 | 6,823 | ||||||||||
| Total | 20,785 | 24,133 | 10,493 | 12,056 | ||||||||||
![]() | Q2 FY2026 | |||||||
| Six Months Ended December 31 | Three Months Ended December 31 | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| Closing number of total employees (including directors) | 11,385 | 11,668 | 11,385 | 11,668 | ||||||||||
| Average operational employees | 10,329 | 10,541 | 10,326 | 10,456 | ||||||||||
| Top 10 customers % | 35% | 34% | 35% | 36% | ||||||||||
| Number of clients with > £1m of revenue (rolling 12 months) | 135 | 141 | 135 | 141 | ||||||||||
| Geographic split of revenue % | ||||||||||||||
| North America | 41 | % | 39 | % | 40 | % | 39 | % | ||||||
| Europe | 23 | % | 24 | % | 23 | % | 24 | % | ||||||
| UK | 30 | % | 32 | % | 31 | % | 32 | % | ||||||
| Rest of World (RoW) | 6 | % | 5 | % | 6 | % | 5 | % | ||||||
| Industry vertical split of revenue % | ||||||||||||||
| Payments | 18 | % | 19 | % | 19 | % | 19 | % | ||||||
| Banking and Capital Markets | 22 | % | 18 | % | 22 | % | 19 | % | ||||||
| Insurance | 9 | % | 9 | % | 9 | % | 9 | % | ||||||
| TMT | 17 | % | 20 | % | 16 | % | 19 | % | ||||||
| Mobility | 9 | % | 9 | % | 9 | % | 9 | % | ||||||
| Healthcare | 12 | % | 12 | % | 12 | % | 12 | % | ||||||
| Other | 13 | % | 13 | % | 13 | % | 13 | % | ||||||
![]() | Q2 FY2026 | |||||||
